For a trial that's looking for 14 day and 28 results, with
For a trial that's looking for 14 day and 28 results, with Leronlimab it took 11 times that much time to come out with an inconclusive outcome, no idea about dosage, no help from the FDA, all during a time where 400,000 in this Country alone died. And the FDA probably thinks that it showed everyone the "system" works.
What warp speed showed is that it isn't about healthcare, it's about money. The system of approval is corrupt because the people who get to approve and those who get to apply for approval are corrupt. And the whole approval system is "behind closed doors" so nobody gets to see results in real time, a built in recipe for corruption.
The rigidity of the trials, especially with an unknown virus, is beyond belief. Unable to adapt midstream to something that's working, and the result is, people die for no valid reason.
11
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Exploring the Intravenous Solutions Market The Intravenous Solutions Market is projected to reach an impressive USD 23.96 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 8.0% over the forecast period from 2024 to 2031. This robust growth is largely attributed to the increasing elderly population and the rising incidences of malnutrition among them. As...
Continue Reading
Progressive Corporation Faces Analysts' Revisions After Q3 Results The Progressive Corporation (NYSE: PGR) recently announced its third quarter earnings, which fell short of analysts' expectations. Analysts and investors alike are closely watching how these results will affect the company's future performance. Disappointing Earnings Report In a recent announcement,...
Continue Reading
Overview of the Merger Golden Ocean Group Limited (NASDAQ: GOGL) has recently engaged in a strategic collaboration with CMB.TECH NV (NYSE: CMBT) that underscores its ambition to enhance its operational capabilities. This significant merger was initially outlined in a stock exchange announcement, illustrating the companies' plans to join forces for greater efficiency and...
Continue Reading
Investigation of Zions Bancorp by Johnson Fistel, PLLP Johnson Fistel, PLLP, a well-respected law firm specializing in shareholder rights, has embarked on an important investigation regarding Zions Bancorporation, N.A. (NASDAQ: ZION). This inquiry focuses on potential violations of federal securities laws which may have affected investors, particularly regarding...
Continue Reading
Anticipated Growth for Planet Fitness Shares of Planet Fitness Inc (NYSE: PLNT) have shown promising activity in early trading, reflecting a potentially strong outlook. The upcoming fourth-quarter earnings report is capturing market attention, as analysts anticipate robust growth driven by strategic pricing adjustments. Price Adjustments and Market Response The increase...
Continue Reading
